Advertisement

Topics

Companies Related to "Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab" [Most Relevant Company Matches] RSS

09:03 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab" found in our extensive corporate database of over 50,000 company records.

Showing "Biomarkers Samples From Patients With Follicular Lymphoma Treated" Companies 1–25 of 4,200+

Relevant

The Lymphoma Research Foundation

The Lymphoma Research Foundation (LRF) is the nation's largest voluntary health organization devoted exclusively to funding lymphoma research and providing patients and healthcare professionals with critical information on the disease. LRF's mission is to eradicate lymphoma and serve those touched by this disease.


Vivomicx

We identify: real biomarkers for drug efficacy to speed up your development process Using this, you can relate true molecular effects to disease activity and the value of your biomarkers We Validate: the pharmacological identity of your NME in complex tissues in vivo, before your drug enters clinical testing the expression of your new putative targets in patient materials your biomarkers...

Verastem Oncology

Verastem, Inc. (Nasdaq:VSTM), operating as Verastem Oncology, is a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients. Verastem Oncology is currently developing duvelisib, a dual inhibitor of PI3K-delta and PI3K-gamma, which has successfully met its primary endpoint i...


Lymphoma Research Foundation

The Lymphoma Research Foundation (LRF) is the nation's largest non-profit organization devoted to funding innovative research and providing people with lymphoma and healthcare professionals with up-to-date information about this type of cancer. LRF's mission is to eradicate lymphoma and serve those touched by this disease.

NeuroPointDX

NeuroPointDX is the diagnostics division of Stemina Biomarker Discovery. Stemina is a biotechnology company based in Madison, WI and Cambridge, MA that has developed a robust and reproducible proprietary platform for identifying changes in metabolism (“biomarkers”) utilizing highly sensitive analytical equipment and its proprietary platform technology. ...

The Leukemia & Lymphoma Society (LLS)

The Leukemia & Lymphoma Society (® )(LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.

Washington Gas and Leukemia & Lymphoma Society (LLS)

The Leukemia & Lymphoma Society ® (LLS) is the world’s largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information a...

The Leukemia & Lymphoma Society and Reliant Energy

The Leukemia & Lymphoma Society ® (LLS) is the world’s largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and supp...

The Cancer Support Community

Fielded by Harris Interactive and commissioned by the CSC, with support from Cephalon Oncology, the survey was distributed online within the United States and completed by 150 hematologists/oncologists and 133 indolent lymphoma patients, equaling 283 respondents in total. Indolent lymphoma patients participated in the survey from June 23-30, 2010, and hematologists/oncologists completed the surve...

Favrille

We are a biopharmaceutical company focused on the development and commercialization of patient-specific immunotherapies for the treatment of cancer and other diseases of the immune system. We own a proprietary technology that enables us to efficiently develop and manufacture active immunotherapy products designed to stimulate a patient's own immune system to mount a specific and sustained response...

Banyan Biomarkers, Inc.

Banyan Biomarkers is the leader in developing in vitro diagnostic products to address unmet clinical needs for the detection of traumatic brain injury. The Company is focused on developing a simple point-of-care blood test that will be used by physicians to detect the presence and severity of brain trauma and improve the medical management of head i...

Biovest International, Inc.

Biovest International, Inc. is an emerging leader in the field of active personalized immunotherapies targeting life-threatening cancers of the blood system. Developed in collaboration with the National Cancer Institute, BiovaxID® is a patient-specific, cancer vaccine, demonstrating statistically significant Phase III clinical benefit by prolonging dise...

Update Pharma Inc.

Update Pharma Inc. is developing UPI-928, an agent developed in the 1980’s by Lederle Laboratories in 44 phase 1, 2 and 3 clinical trials, including 33 clinical trials at the National Cancer Institute. Despite an acceptable safety database of over 2,000 treated patients, over 70 peer reviewed clinical publications that demonstrated efficacy in leukemi...

Genitope

Genitope Corporation is a biotechnology company focused on the research and development of novel immunotherapies for the treatment of cancer. Immunotherapy products are designed to utilize the immune system to combat diseases such as cancer. Our lead product candidate, MyVax® Personalized Immunotherapy (previously referred to as GTOP-99) is currently in a pivotal Phase 3 trial for the treatment o...

Dr. Larry J. Shapiro

Dr. Larry J. Shapiro is a world renowned hair transplant surgeon and one of the world's leading experts on hair loss. With offices in Delray Beach and Hollywood, Shapiro has practiced in South Florida since 1989. He began specializing solely in hair transplants in 2003. Dr. Shapiro was the first doctor in the U.S. to do the strip incision and micro/mini graft, follicular unit technique. He has...

Shape Pharmaceuticals, Inc.

Shape Pharmaceuticals, Inc. is developing SHP-141, a novel, topical, “soft-drug” HDAC inhibitor for the treatment of patients with cutaneous T cell lymphoma (CTCL) and psoriasis. Shape has an ongoing Phase 1b clinical study in CTCL patients and has completed a Phase 1b clinical study in psoriasis patients. The development of SHP-141 is being supp...

The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society ® (LLS) is the world’s largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and supp...

Hotze Health & Wellness Center

Hotze Health & Wellness Center, a part of Hotze Enterprises, is leading the revolution in wellness care by transforming the way patients are treated both internally and externally. Founded in 1989 by Steven F. Hotze, M.D., the Center has successfully treated nearly 20,000 patients. In an effort to help patients obtain and maintain life-long health and well...

Gloucester Pharmaceuticals

Gloucester Pharmaceuticals acquires clinical-stage oncology drug candidates and advances them through regulatory approval and commercialization. The Company’s first candidate, ISTODAX® (romidepsin), a novel histone deacetylase (HDAC) inhibitor, is FDA approved for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at le...

Amplion Inc.

Amplion publishes BiomarkerBase™ (http://www.biomarkerbase.com), the most complete database of biomarkers in clinical use and development. BiomarkerBase™ includes every biomarker used in and FDA-approved test or drug label, and thousands of biomarkers being used and developed in clinical trials. Many of the world’s leading diagnostics and bi...

Miracor Medical Systems GmbH

Based in Vienna, Austria, privately held Miracor is commercializing a unique and potentially disruptive technology, PICSO®, for acute coronary syndrome (ACS), heart failure, and cardiac surgery patients. The Company’s objective is to establish PICSO® as the standard of care for heart attack patients, thereby improving their quality of life. The ...

General Activation Analysis

General Activation Analysis, Inc.tests samples for outside customers. Every year hundreds of companies, from all parts of the world, send samples for elemental determinations. Some of the more interesting samples include bullets from homicide cases, parts from the Space Shuttle, hair to determine Arsenic poisoning, paint from old paintings and very, very small glass balls used in fusion experiment...

Orion Genomics.

Orion Genomics develops oncology diagnostic products for cancer screening and therapy selection. We leverage our suite of proprietary technologies to find and interpret normal and abnormal epigenetic patterns of DNA methylation, also known as DNA's Second Code.We are currently identifying epigenetic biomarkers and employing them in the development of novel molecular diagnostic tests to find breast...

Tethys Bioscience

Tethys Bioscience was founded in 2002 by two biotechnology veterans, Mickey S. Urdea and Gregory T. Went, with an emphasis on applying new technologies and techniques to the problems of getting novel diagnostics products to market faster, more efficiently, and with less cost. he company successfully concluded its Series A funding in 2005. At that time, Michael McKenna and Mike Richey joined the co...

Be The Match

For people with life-threatening blood cancers—like leukemia and lymphoma—or other diseases, a cure exists. Be The Match connects patients with their donor match for a life-saving marrow or umbilical cord blood transplant. People can contribute to the cure as a member of the Be The Match Registry, financial contributor or volunteer. Be The Match ...


More From BioPortfolio on "Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks